Latest Global Markets News

Skin Elements Limited reports steady progress in commercialising its plant-based SE Formula biotechnology, highlighted by ongoing product trials, a successful R&D rebate, and a $513k non-renounceable entitlement issue.

Merino & Co’s successful IPO has injected $6.35 million into the company, enabling a strategic expansion of manufacturing capacity and securing a new facility in Western Australia. The company is now poised to scale globally with automated production and enhanced distribution capabilities.

Citigroup Global Markets Australia has announced a fully franked dividend of AUD 0.32 for its CCP Citi Instalments, with key dates set for mid-March 2025. Investors should note the ex-dividend trading start and payment schedule aligning with CCP Ordinary shares.

Larvotto Resources has reported robust progress at its Hillgrove Antimony-Gold Project, highlighted by exceptional drilling results and a successful $30 million capital raise, positioning the company for production by late 2025.

Pure Resources Limited has made significant strides in its Reedy Creek Garnet Project, expanding the resource and delivering promising metallurgical test results that highlight the project's commercial potential.

Krakatoa Resources has taken a major step by signing an option to acquire an 80% interest in the Zopkhito antimony-gold project in Georgia, complementing a $220,000 drilling grant for its Mt Clere REE project and a $1.18 million capital raise.

Arrow Minerals reports a breakthrough at its Niagara Bauxite Project with high-grade mineralisation over 14km² and advances metallurgical testwork at Simandou North, backed by a $7 million funding round.

First Lithium Limited reports promising metallurgical testwork results and an imminent maiden Mineral Resource Estimate, underpinning its Mali lithium projects amid ongoing license renewal progress.

Noumi Limited’s Q2 FY25 results reveal a resilient plant-based milks segment driving growth, even as traditional dairy and nutritionals face margin pressures amid a challenging market.

Linius Technologies has appointed Ben Taverner as CEO and secured key partnerships and customers, including Brown University and Fujitsu, setting the stage for significant growth in FY25.

Osteopore Limited reports a robust 27% year-over-year revenue increase despite operational headwinds, underpinned by new collaborations in stem cell therapies and expanded market access in Brazil and Singapore.

Mesoblast has secured FDA approval for Ryoncil®, the first mesenchymal stromal cell therapy for steroid-refractory acute graft versus host disease in children, while raising A$260 million to accelerate clinical trials and commercial rollout.